Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Italie
BIT
Abitare In Spa (ABT)
Abitare In Spa (ABT) Actualités

ABT

Abitare In (ABT)

Abitare In Spa

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:BIT:ABT

<< Précédent 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/05/2008	07h02	PR Newswire (US)	Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System	NYSE:ABT
01/05/2008	15h00	PR Newswire (US)	Abbott, Takeda Conclude TAP Joint Venture	NYSE:ABT
24/04/2008	16h03	PR Newswire (US)	Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners	NYSE:ABT
19/03/2008	21h09	PR Newswire (US)	Takeda, Abbott Announce Plans to Conclude TAP Joint Venture	NYSE:ABT
15/02/2008	22h55	PR Newswire (US)	Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholestero	NYSE:ABT
13/02/2008	18h51	PR Newswire (US)	On Valentine's Day, Abbott Urges Women to Take Heart With Launch of 'Faces of Heart Disease' Exhibit to Raise Heart Health Aware	NYSE:ABT
01/12/2007	18h29	PR Newswire (US)	Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American Wome	NYSE:ABT
01/12/2007	11h00	PR Newswire (US)	Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet	NYSE:ABT
27/11/2007	17h08	PR Newswire (US)	Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29	NYSE:ABT
21/11/2007	17h47	PR Newswire (US)	Abbott's Environmental Protection Initiatives Again Recognized by the State of Illinois	NYSE:ABT
21/11/2007	16h39	PR Newswire (US)	Abbott Employees Give Back to Local Communities This Holiday Season	NYSE:ABT
12/11/2007	19h15	PR Newswire (US)	Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pe	NYSE:ABT
08/11/2007	14h03	PR Newswire (US)	New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays	NYSE:ABT
29/10/2007	16h01	PR Newswire (US)	Abbott Employees Provide Healthy Treats to Ghosts and Goblins Across United States	NYSE:ABT
17/10/2007	13h42	PR Newswire (US)	Abbott Reports 14.4 Percent Sales Growth in Third Quarter	NYSE:ABT
10/10/2007	14h01	PR Newswire (US)	Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine	NYSE:ABT
25/09/2007	13h01	PR Newswire (US)	Abbott Again Honored as Top Company for Working Moms	NYSE:ABT
13/09/2007	15h15	PR Newswire (US)	Abbott Awards Arizona Mother $135,000 in National Similac(R) Contest	NYSE:ABT
31/08/2007	15h01	PR Newswire (US)	Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination	NYSE:ABT
29/06/2007	00h36	PR Newswire (US)	Abbott and Abbott Fund Expand Commitment to Improving Health Care in Tanzania With Dedication of New Lab and Launch of New Diagn	NYSE:ABT
13/06/2007	15h15	PR Newswire (US)	Global Business Coalition on HIV/AIDS, TB and Malaria (GBC) Honors Abbott and Abbott Fund for Efforts to Fight HIV/AIDS in Tanza	NYSE:ABT
12/06/2007	21h25	PR Newswire (US)	Abbott to Present at Goldman Sachs Healthcare Conference	NYSE:ABT
04/06/2007	17h36	PR Newswire (US)	First Bright Space Developed to Give Children Living With Substance Abuse a Dedicated Play and Learning Environment	NYSE:ABT
27/04/2007	13h27	PR Newswire (US)	Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn.s Disease	NYSE:ABT
25/04/2007	16h01	PR Newswire (US)	Abbott to Present at Morgan Stanley Healthcare Conference	NYSE:ABT
23/04/2007	18h00	PR Newswire (US)	Abbott and Abbott Fund Provide $1 Million to HealthReach to Increase Access to Care and Expand Services at Area's Only Free Heal	NYSE:ABT
02/04/2007	15h00	PR Newswire (US)	Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis	NYSE:ABT
24/03/2007	17h00	PR Newswire (US)	Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary	NYSE:ABT
23/03/2007	22h57	PR Newswire (US)	Abbott Named to DiversityInc's 'Top 50 Companies for Diversity' List	NYSE:ABT
05/03/2007	16h01	PR Newswire (US)	Abbott Donates Diagnostic Equipment and Supplies to 16 Clinical Laboratory Programs as Part of 'Labs are Vital(TM)' Initiative	NYSE:ABT